tiprankstipranks
Trending News
More News >
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market
Advertisement

Agios Pharma (AGIO) Ratios

Compare
639 Followers

Agios Pharma Ratios

AGIO's free cash flow for Q2 2025 was $0.86. For the 2025 fiscal year, AGIO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
14.48 12.27 13.30 17.79 6.74
Quick Ratio
14.04 11.99 13.16 17.52 6.59
Cash Ratio
1.15 1.30 2.22 3.40 1.35
Solvency Ratio
6.43 -2.74 -0.41 11.14 -0.70
Operating Cash Flow Ratio
-5.77 -4.36 -4.94 -6.81 -3.08
Short-Term Operating Cash Flow Coverage
-23.08 0.00 0.00 0.00 -39.24
Net Current Asset Value
$ 917.78M$ 707.74M$ 694.87M$ 918.47M$ 183.22M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.08 0.07 0.07 0.12
Debt-to-Equity Ratio
0.04 0.09 0.08 0.08 0.26
Debt-to-Capital Ratio
0.03 0.08 0.07 0.07 0.21
Long-Term Debt-to-Capital Ratio
0.02 0.00 0.00 0.00 0.20
Financial Leverage Ratio
1.07 1.16 1.13 1.11 2.14
Debt Service Coverage Ratio
-28.60 0.00 -17.45 0.00 -13.23
Interest Coverage Ratio
0.00 0.00 -30.41 0.00 -17.73
Debt to Market Cap
0.02 0.00 0.00 0.00 0.04
Interest Debt Per Share
0.84 1.29 1.80 1.61 1.78
Net Debt to EBITDA
0.07 0.04 0.14 0.31 0.07
Profitability Margins
Gross Profit Margin
88.18%64.57%88.03%0.00%98.62%
EBIT Margin
-818.29%-1459.52%-2732.07%0.00%-165.32%
EBITDA Margin
-1122.66%-1434.83%-2671.93%0.00%-160.50%
Operating Profit Margin
-1129.13%-1459.52%-2732.07%0.00%-155.59%
Pretax Profit Margin
1698.66%-1312.63%-1627.82%0.00%-161.11%
Net Profit Margin
1590.42%-1312.63%-523.56%0.00%-164.97%
Continuous Operations Profit Margin
1864.47%-1312.63%-1627.82%0.00%-162.06%
Net Income Per EBT
93.63%100.00%32.16%-450.12%102.40%
EBT Per EBIT
-150.44%89.94%59.58%94.21%103.55%
Return on Assets (ROA)
44.19%-37.57%-6.02%111.61%-39.30%
Return on Equity (ROE)
43.31%-43.41%-6.77%124.21%-83.91%
Return on Capital Employed (ROCE)
-32.95%-45.04%-33.08%-27.46%-41.68%
Return on Invested Capital (ROIC)
-30.47%-44.28%-10.52%123.90%-41.86%
Return on Tangible Assets
44.19%-37.57%-6.02%111.61%-39.30%
Earnings Yield
30.99%-28.41%-4.85%80.76%-11.21%
Efficiency Ratios
Receivables Turnover
8.20 9.55 6.46 0.00 0.00
Payables Turnover
0.28 0.97 0.09 1.12 0.16
Inventory Turnover
0.16 0.50 0.20 1.16 0.19
Fixed Asset Turnover
0.86 0.38 0.16 0.00 1.73
Asset Turnover
0.03 0.03 0.01 0.00 0.24
Working Capital Turnover Ratio
0.04 0.03 0.02 0.00 0.38
Cash Conversion Cycle
1.05K 395.25 -2.11K -9.91 -393.76
Days of Sales Outstanding
44.52 38.24 56.54 0.00 0.00
Days of Inventory Outstanding
2.33K 732.61 1.82K 314.71 1.91K
Days of Payables Outstanding
1.32K 375.60 3.99K 324.63 2.31K
Operating Cycle
2.38K 770.85 1.88K 314.71 1.91K
Cash Flow Ratios
Operating Cash Flow Per Share
-7.01 -5.32 -5.65 -6.74 -4.21
Free Cash Flow Per Share
-7.06 -5.34 -5.74 -6.83 -4.43
CapEx Per Share
0.05 0.02 0.09 0.09 0.22
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.02 1.01 1.05
Dividend Paid and CapEx Coverage Ratio
-134.13 -296.36 -63.40 -70.95 -19.50
Capital Expenditure Coverage Ratio
-134.13 -296.36 -63.40 -70.95 -19.50
Operating Cash Flow Coverage Ratio
-8.33 -4.11 -3.61 -4.20 -2.76
Operating Cash Flow to Sales Ratio
-9.93 -11.04 -21.73 0.00 -1.43
Free Cash Flow Yield
-19.44%-23.97%-20.43%-20.79%-10.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.23 -3.52 -20.64 1.24 -8.92
Price-to-Sales (P/S) Ratio
51.47 46.21 108.04 0.00 14.71
Price-to-Book (P/B) Ratio
1.53 1.53 1.40 1.54 7.48
Price-to-Free Cash Flow (P/FCF) Ratio
-5.14 -4.17 -4.89 -4.81 -9.78
Price-to-Operating Cash Flow Ratio
-5.17 -4.19 -4.97 -4.88 -10.28
Price-to-Earnings Growth (PEG) Ratio
-1.57 >-0.01 0.20 >-0.01 0.34
Price-to-Fair Value
1.53 1.53 1.40 1.54 7.48
Enterprise Value Multiple
-4.51 -3.18 -3.90 -5.57 -9.10
Enterprise Value
2.07B 1.22B 1.48B 1.88B 2.97B
EV to EBITDA
-4.51 -3.18 -3.90 -5.57 -9.10
EV to Sales
50.68 45.60 104.28 0.00 14.60
EV to Free Cash Flow
-5.07 -4.12 -4.72 -4.55 -9.71
EV to Operating Cash Flow
-5.10 -4.13 -4.80 -4.62 -10.21
Tangible Book Value Per Share
23.64 14.57 20.09 21.37 5.79
Shareholders’ Equity Per Share
23.64 14.57 20.09 21.37 5.79
Tax and Other Ratios
Effective Tax Rate
0.06 0.00 0.68 5.55 -0.02
Revenue Per Share
0.71 0.48 0.26 0.00 2.94
Net Income Per Share
11.22 -6.33 -1.36 26.55 -4.86
Tax Burden
0.94 1.00 0.32 -4.50 1.02
Interest Burden
-2.08 0.90 0.60 1.00 0.97
Research & Development to Revenue
7.83 10.77 19.66 0.00 1.81
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
1.18 1.67 3.46 0.00 0.30
Income Quality
-0.62 0.84 1.34 1.14 0.89
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis